Long-Term Survivorship After Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies Using the Enhancing Quality and Transparency of Health Research (EQUATOR) Network's methodological ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results